About this trial
Randomized clinical trial, parallel 1:1, comparing Latarjet to Modified Eden-Hybinette (iliac bone crest + capsular repair) for recurrent traumatic anterior glenohumeral dislocation.
Eligibility criteria
Qualifiers
History of one or more previous episodes of traumatic glenohumeral dislocation;
Anterior glenoid bone loss superior to 20% of its diameter, regardless of the ISIS score;
Recurrence of glenohumeral dislocation in cases previously treated with arthroscopic Bankart repair, regardless of the ISIS score and severity of bone lesion of the glenoid;
Instability Severity Index Score of (ISIS) greater than or equal to 4 points, with anterior glenoid bone loss (bone Bankart lesion) greater than 13.5% of their diameter, measured by the method described by Sugaya et al.;
Disqualifiers
Hill-Sachs lesion greater than 40% of the humeral head diameter (measured by the preoperative CT);
Untreated seizures;
Previously diagnosed rotator cuff complete tear;
Fractures of the proximal humerus (except for Hill-Sachs lesions);
Trial design
Treatments tested in this trial
- Latarjet procedure
- Modified Eden-Hybinette
Treatment groups
Sponsors and collaborators
University of Sao Paulo
Lead sponsor
Faculdade de Medicina de Jundiaí
Collaborator